** Shares in Danish allergy solutions maker Alk-Abello ALKb.CO rise more than 12% after it reported a beat on the sales and profit lines and hiked its outlook
** The company's Q3 sales at DKK 1,530 million ($238.95 million) are 4% ahead of the consensus cited by Jefferies; similarly its quarterly EBIT and EBIT margin also beat expectations
** The company hikes its FY outlook, expecting revenue to grow by 13-15% (prev.: 12-14%), and EBIT margin target increased to close to 26% (prev.: close to 25%)
** If gains hold, Alk-Abello shares will track their best day in 1-1/2 year
($1 = 6.4029 Danish crowns)
(Reporting by Elviira Luoma)
((Elviira.luoma@thomsonreuters.com))